Artificial Pancreas Device System (apds) Market By Type- Global Industry Analysis And Forecast To 2023

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.1.1.    Huge Diabetes monitoring and management market

3.2.1.2.    Success of continuous glucose monitoring systems and increasing development

3.2.2.  Restraints

3.2.2.1.    High Cost of Implementation

3.2.2.2.    Regulatory Obstacles

3.2.2.3.    Developing a Quick Acting Insulin and Glucagon Formula

3.2.3.  Opportunities

3.2.3.1.    Comprehensive Investments in R&D

3.2.3.2.    Evolution of Next Generation Sensors

3.2.3.3.    Use of Inhaled Insulin APDS

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2023)

4.1.2.  Canada Market States and Outlook (2017-2023)

4.1.3.  Mexico Market States and Outlook (2017-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2023)

4.2.2.  France Market States and Outlook (2017-2023)

4.2.3.  UK Market States and Outlook (2017-2023)

4.2.4.  Russia Market States and Outlook (2017-2023)

4.2.5.  Italy Market States and Outlook (2017-2023)

4.2.6.  Rest of Europe Market States and Outlook (2017-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2023)

4.3.2.  Japan Market States and Outlook (2017-2023)

4.3.3.  Korea Market States and Outlook (2017-2023)

4.3.4.  India Market States and Outlook (2017-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2017-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2023)

4.4.2.  Argentina Market States and Outlook (2017-2023)

4.4.3.  Columbia Market States and Outlook (2017-2023)

4.4.4.  Rest of South America Market States and Outlook (2017-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2023)

4.5.2.  UAE Market States and Outlook (2017-2023)

4.5.3.  Egypt Market States and Outlook (2017-2023)

4.5.4.  Nigeria Market States and Outlook (2017-2023)

4.5.5.  South Africa Market States and Outlook (2017-2023)

4.5.6.  Rest of MEA Market States and Outlook (2017-2023)

5.       Artificial Pancreas Device System Market, By Type

5.1.       Introduction

5.2.       Global Artificial Pancreas Device System Sales, Revenue and Market Share By Type (2017-2027)

5.2.1.  Global Artificial Pancreas Device System Sales and Sales Share By Type (2017-2027)

5.2.2.  Global Artificial Pancreas Device System Revenue and Revenue Share By Type (2017-2027)

5.3.       Threshold Suspended Device Systems

5.3.1.  Global Threshold Suspended Device Systems Sales and Growth Rate (2017-2027)

5.4.       Treat to Range/Control to Range (TTR/CTR)

5.4.1.  Global Treat to Range/Control to Range (TTR/CTR) Sales and Growth Rate (2017-2027)

5.5.       Treat to Target/ Control to Target (TTR/CTT)

5.5.1.  Global Treat to Target/ Control to Target (TTR/CTT) Sales and Growth Rate (2017-2027)

6.       Artificial Pancreas Device System Market, By Region

6.1.       Introduction

6.2.       Global Artificial Pancreas Device System Sales, Revenue and Market Share by Regions

6.2.1.  Global Artificial Pancreas Device System Sales by Regions (2017-2027)

6.2.2.  Global Artificial Pancreas Device System Revenue by Regions (2017-2027)

6.3.       North America Artificial Pancreas Device System by Countries

6.3.1.  North America Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.3.2.  North America Artificial Pancreas Device System Revenue and Growth Rate (2017-2027)

6.3.3.  North America Artificial Pancreas Device System Sales by Countries (2017-2027)

6.3.4.  North America Artificial Pancreas Device System Revenue (Million USD) by Countries (2017-2027)

6.3.5.  U.S.

6.3.5.1.    United States Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.3.5.2.    United States Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.6.  Canada

6.3.6.1.    Canada Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.3.6.2.    Canada Artificial Pancreas Device System Sales (Millions USD) and Growth Rate (2017-2027)

6.3.7.  Mexico

6.3.7.1.    Mexico Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.3.7.2.    Mexico Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.       Europe Artificial Pancreas Device System by Countries

6.4.1.  Europe Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.4.2.  Europe Artificial Pancreas Device System Revenue and Growth Rate (2017-2027)

6.4.3.  Europe Artificial Pancreas Device System Sales by Countries (2017-2027)

6.4.4.  Europe Artificial Pancreas Device System Revenue (Million USD) by Countries (2017-2027)

6.4.5.  Germany

6.4.5.1.    Germany Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.4.5.2.    Germany Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.6.  UK

6.4.6.1.    UK Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.4.6.2.    UK Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.7.  France

6.4.7.1.    France Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.4.7.2.    France Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.8.  Russia

6.4.8.1.    Russia Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.4.8.2.    Russia Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.9.  Italy

6.4.9.1.    Italy Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.4.9.2.    Italy Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.10.      Rest of Europe

6.4.10.1. Rest of Europe Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.4.10.2. Rest of Europe Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.       Asia-Pacific

6.5.1.  Asia-Pacific Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.5.2.  Asia-Pacific Artificial Pancreas Device System Revenue and Growth Rate (2017-2027)

6.5.3.  Asia-Pacific Artificial Pancreas Device System Sales by Countries (2017-2027)

6.5.4.  Asia-Pacific Artificial Pancreas Device System Revenue (Million USD) by Countries (2017-2027)

6.5.5.  China

6.5.5.1.    China Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.5.5.2.    China Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.6.  Japan

6.5.6.1.    Japan Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.5.6.2.    Japan Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.7.  Korea

6.5.7.1.    Korea Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.5.7.2.    Korea Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.8.  India

6.5.8.1.    India Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.5.8.2.    India Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.9.  Southeast Asia

6.5.9.1.    Southeast Asia Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.5.9.2.    Southeast Asia Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.10.      Rest of Asia-Pacific

6.5.10.1. Rest of Asia-Pacific Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.5.10.2. Rest of Asia-Pacific Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.       South America

6.6.1.  South America Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.6.2.  South America Artificial Pancreas Device System Revenue and Growth Rate (2017-2027)

6.6.3.  South America Artificial Pancreas Device System Sales by Countries (2017-2027)

6.6.4.  South America Artificial Pancreas Device System Revenue (Million USD) by Countries (2017-2027)

6.6.5.  Brazil

6.6.5.1.    Brazil Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.6.5.2.    Brazil Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.6.  Argentina

6.6.6.1.    Argentina Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.6.6.2.    Argentina Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.7.  Columbia

6.6.7.1.    Columbia Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.6.7.2.    Columbia Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.8.  Rest of South America

6.6.8.1.    Rest of South America Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.6.8.2.    Rest of South America Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.       Middle East and Africa

6.7.1.  Middle East and Africa Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.7.2.  Middle East and Africa Artificial Pancreas Device System Revenue and Growth Rate (2017-2027)

6.7.3.  Middle East and Africa Artificial Pancreas Device System Sales by Countries (2017-2027)

6.7.4.  Middle East and Africa Artificial Pancreas Device System Revenue (Million USD) by Countries (2017-2027)

6.7.5.  Saudi Arabia

6.7.5.1.    Saudi Arabia Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.7.5.2.    Saudi Arabia Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.6.  United Arab Emirates

6.7.6.1.    United Arab Emirates Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.7.6.2.    United Arab Emirates Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.7.  Egypt

6.7.7.1.    Egypt Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.7.7.2.    Egypt Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.8.  Nigeria

6.7.8.1.    Nigeria Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.7.8.2.    Nigeria Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.9.  South Africa

6.7.9.1.    South Africa Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.7.9.2.    South Africa Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.10.      Rest of Middle East and Africa

6.7.10.1. Rest of Middle East and Africa Artificial Pancreas Device System Sales and Growth Rate (2017-2027)

6.7.10.2. Rest of Middle East and Africa Artificial Pancreas Device System Revenue (Millions USD) and Growth Rate (2017-2027)

7.       Company Profiles

7.1.         Pancreum LLC

7.1.1.  Business Overview

7.1.2.  Product Portfolio

7.1.3.  Strategic Developments

7.1.4.  Sales, Revenue and Market Share

7.2.       Tandem Diabetes Care

7.2.1.  Business Overview

7.2.2.  Product Portfolio

7.2.3.  Strategic Developments

7.2.4.  Sales, Revenue and Market Share

7.3.       Medtronic

7.3.1.  Business Overview

7.3.2.  Product Portfolio

7.3.3.  Strategic Developments

7.3.4.  Sales, Revenue and Market Share

7.4.       Johnson & Johnson

7.4.1.  Business Overview

7.4.2.  Product Portfolio

7.4.3.  Strategic Developments

7.4.4.  Sales, Revenue and Market Share

7.5.       Roche

7.5.1.  Business Overview

7.5.2.  Product Portfolio

7.5.3.  Strategic Developments

7.5.4.  Sales, Revenue and Market Share

7.6.       Insulet

7.6.1.  Business Overview

7.6.2.  Product Portfolio

7.6.3.  Strategic Developments

7.6.4.  Sales, Revenue and Market Share

7.7.        Beta Bionics

7.7.1.  Business Overview

7.7.2.  Product Portfolio

7.7.3.  Strategic Developments

7.7.4.  Sales, Revenue and Market Share

7.8.       Inreda Diabetic BV

7.8.1.  Business Overview

7.8.2.  Product Portfolio

7.8.3.  Strategic Developments

7.8.4.  Sales, Revenue and Market Share

7.9.       Medtrum

7.9.1.  Business Overview

7.9.2.  Product Portfolio

7.9.3.  Strategic Developments

7.9.4.  Sales, Revenue and Market Share

7.10.    Bigfoot Biomedical

7.10.1.      Business Overview

7.10.2.      Product Portfolio

7.10.3.      Strategic Developments

7.10.4.      Sales, Revenue and Market Share

7.11.    TypeZero Technologies, Inc.

7.11.1.      Business Overview

7.11.2.      Product Portfolio

7.11.3.      Strategic Developments

7.11.4.      Sales, Revenue and Market Share

7.12.    DreaMed Diabetes Ltd

7.12.1.      Business Overview

7.12.2.      Product Portfolio

7.12.3.      Strategic Developments

7.12.4.      Sales, Revenue and Market Share

8.       Global Artificial Pancreas Device System Competition, by Manufacturer

8.1.       Global Artificial Pancreas Device System Sales and Market Share by Manufacturer (2017-2017)

8.2.       Global Artificial Pancreas Device System Revenue and Market Share by Manufacturer (2017-2017)

8.3.       Global Artificial Pancreas Device System Price by Manufacturer (2017-2017)

8.4.       Top 5 Artificial Pancreas Device System Manufacturer Market Share

8.5.       Market Competition Trend

9.       Artificial Pancreas Device System Forecast (2027-2023)

9.1.       Global Artificial Pancreas Device System Sales, Revenue (Millions USD) and Growth Rate (2027-2023)

9.2.       Artificial Pancreas Device System Forecast by Regions (2027-2023)

9.2.1.  North America Artificial Pancreas Device System Forecast (2027-2023)

9.2.1.1.    United States Artificial Pancreas Device System Forecast (2027-2023)

9.2.1.2.    Canada Artificial Pancreas Device System Forecast (2027-2023)

9.2.1.3.    Mexico Artificial Pancreas Device System Forecast (2027-2023)

9.2.2.  Europe Artificial Pancreas Device System Forecast (2027-2023)

9.2.2.1.    Germany Artificial Pancreas Device System Forecast (2027-2023)

9.2.2.2.    United Kingdom Artificial Pancreas Device System Forecast (2027-2023)

9.2.2.3.    France Artificial Pancreas Device System Forecast (2027-2023)

9.2.2.4.    Russia Artificial Pancreas Device System Forecast (2027-2023)

9.2.2.5.    Italy Artificial Pancreas Device System Forecast (2027-2023)

9.2.2.6.    Rest of the Europe Artificial Pancreas Device System Forecast (2027-2023)

9.2.3.  Asia-Pacific Artificial Pancreas Device System Forecast (2027-2023)

9.2.3.1.    China Artificial Pancreas Device System Forecast (2027-2023)

9.2.3.2.    Japan Artificial Pancreas Device System Forecast (2027-2023)

9.2.3.3.    Korea Artificial Pancreas Device System Forecast (2027-2023)

9.2.3.4.    India Artificial Pancreas Device System Forecast (2027-2023)

9.2.3.5.    Southeast Asia Artificial Pancreas Device System Forecast (2027-2023)

9.2.3.6.    Rest of Asia-Pacific Artificial Pancreas Device System Forecast (2027-2023)

9.2.4.  South America Artificial Pancreas Device System Forecast (2027-2023)

9.2.4.1.    Brazil Artificial Pancreas Device System Forecast (2027-2023)

9.2.4.2.    Argentina Artificial Pancreas Device System Forecast (2027-2023)

9.2.4.3.    Columbia Artificial Pancreas Device System Forecast (2027-2023)

9.2.4.4.    Rest of South America Artificial Pancreas Device System Forecast (2027-2023)

9.2.5.  Middle East and Africa Artificial Pancreas Device System Forecast (2027-2023)

9.2.5.1.    Saudi Arabia Artificial Pancreas Device System Forecast (2027-2023)

9.2.5.2.    UAE Artificial Pancreas Device System Forecast (2027-2023)

9.2.5.3.    Egypt Artificial Pancreas Device System Forecast (2027-2023)

9.2.5.4.    Nigeria Artificial Pancreas Device System Forecast (2027-2023)

9.2.5.5.    South Africa Artificial Pancreas Device System Forecast (2027-2023)

9.2.5.6.    Rest of MEA Artificial Pancreas Device System Forecast (2027-2023)

9.3.       Artificial Pancreas Device System Forecast By Type (2027-2023)

9.3.1.  Global Artificial Pancreas Device System Sales Forecast By Type(2027-2023)

9.3.2.  Global Artificial Pancreas Device System Sales Market Share Forecast By Type (2027-2023)

9.4.       Artificial Pancreas Device System Forecast by Deployment Mode (2027-2023)

9.4.1.  Global Artificial Pancreas Device System Sales Forecast by Deployment Mode (2027-2023)

9.4.2.  Global Artificial Pancreas Device System Sales Market Share Forecast by Deployment Mode (2027-2023)

9.5.       Artificial Pancreas Device System Forecast by End User (2027-2023)

9.5.1.  Global Artificial Pancreas Device System Sales Forecast by End User (2027-2023)

9.5.2.  Global Artificial Pancreas Device System Sales Market Share Forecast by End User (2027-2023)

---

List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Artificial Pancreas Device System Market.

---

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

• Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

• Number of patients for particular device or medical procedure and
• Repeated use of particular device depending on health and condition of patient

• Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country